Special cells called L-cells in your small intestine detect the presence of amino acids (proteins building blocks) and respond by releasing GLP-1 into your bloodstream
Common side effects may include nausea, reduced appetite, mild gastrointestinal discomfort, or temporary digestive changes, particularly during dose escalation
Additional information Prior Presentation : Utilization patterns of glucagon-like peptide receptor agonists in patients with type 2 diabetes in France and Italy, presented at the International Society for Pharmacoeconomics and Outcomes Research26th Annual European Congress (ISPOR-EU 2023)
Table 1 Clinical studies of GLP-1 receptor agonists in psoriasis (PsO) and psoriatic arthritis (PsA) (chronological order of publications)
Semaglutide acts like just one hormone, GLP-1
Seiwerth, Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing, J